HHS Approps Bill Includes Cancer Screening, Flu Provisions
This article was originally published in The Gray Sheet
Executive Summary
In addition to FDA, funding to other Department of Health and Human Services agencies would be impacted by a hold up in the appropriations process. A $154.9 billion Labor, Health and Human Services, Education, and Related Agencies funding bill made its way through the Senate Appropriations Committee late last month, despite the standstill in the House. The legislation contains a few provisions relevant to the device industry, including about $38 million designated for colorectal cancer prevention efforts, $25 million of which would go to establish a national surveillance campaign to support screening efforts. It also calls for more federal funding of research and development of imaging technologies to detect and treat prostate cancer. Further, it targets $507 million for the development and purchase of vaccines, drugs, medical supplies and diagnostics for pandemic flu.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.